ReviewJournal of clinical medicine2023
Transcatheter Tricuspid Valve Replacement: Illustrative Case Reports and Review of State-of-Art.
Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 15 citations in OpenAlex.
- Surgical Bailout and Retrieval of Maldeployed Transcatheter Tricuspid Valve: Technical Considerations.JACC. Case reports · 2026Article
- Patient Selection for Transcatheter Tricuspid Valve Intervention: Not Too Early, Not Too Late.Structural heart : the journal of the Heart Team · 2026Review
- CT assessment of right heart anatomy across tricuspid regurgitation severity grades: implications for transcatheter interventions.The international journal of cardiovascular imaging · 2025Article
- Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review.Reviews in cardiovascular medicine · 2025Review
- Long-Term Outcomes of Surgical and Transcatheter Interventions for Tricuspid Regurgitation: A Comprehensive Review.Journal of clinical medicine · 2025Review
- Contemporary Management of Severe Carcinoid Heart Disease.JACC. Case reports · 2025Article
- New Therapeutic Advances in the Management of Tricuspid Valve Regurgitation.Journal of clinical medicine · 2024Review
- Severe Aortic Stenosis Associated with Other Valve Diseases: Open Surgery or Percutaneous Treatment?Reviews in cardiovascular medicine · 2024Review
- Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.Heart international · 2024Review
- Role of computed tomography in transcatheter coronary and structural heart disease interventions.REC, interventional cardiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tricuspid regurgitation (TR) is one of the most common heart valve diseases, associated a with poor prognosis since significant TR is associated with an increased mortality risk compared to no TR or mild regurgitation. Surgery is the standard treatment for TR, although it is associated with high morbidity, mortality, and prolonged hospitalization, particularly in tricuspid reoperation after left-sided surgery. Thus, several innovative percutaneous transcatheter approaches for repair and replacement of the tricuspid valve have gathered significant momentum and have undergone extensive clinical development in recent years, with favorable clinical outcomes in terms of mortality and rehospitalization during the first year of follow-up. We present three clinical cases of transcatheter tricuspid valve replacement in an orthotopic position with two different innovative systems along with a review of the state-of-the-art of this emergent topic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.